|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 364.65 USD | -2.97% |
|
+7.70% | +11.41% |
| 02-10 | Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating | MT |
| 02-10 | Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.51 | 9.4 | 9.97 | 6.16 | 6.4 | |||||
Return on Total Capital | 14.06 | 13.97 | 14.99 | 8.7 | 8.74 | |||||
Return On Equity % | 76.13 | 73.16 | 126.47 | 135.79 | 67.55 | |||||
Return on Common Equity | 76.13 | 73.16 | 126.47 | 135.79 | 67.55 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 75.77 | 75.16 | 75.66 | 70.15 | 68.71 | |||||
SG&A Margin | 22.54 | 20.66 | 20.57 | 21.87 | 21.23 | |||||
EBITDA Margin % | 50.22 | 48.43 | 51.23 | 42.82 | 45.35 | |||||
EBITA Margin % | 47.7 | 45.95 | 48.13 | 39.73 | 43.31 | |||||
EBIT Margin % | 36.69 | 35.94 | 38.25 | 28.38 | 28.95 | |||||
Income From Continuing Operations Margin % | 28.57 | 22.68 | 24.89 | 23.83 | 12.24 | |||||
Net Income Margin % | 28.57 | 22.68 | 24.89 | 23.83 | 12.24 | |||||
Net Avail. For Common Margin % | 28.57 | 22.68 | 24.89 | 23.83 | 12.24 | |||||
Normalized Net Income Margin | 20.38 | 21.35 | 19.59 | 13.95 | 13.01 | |||||
Levered Free Cash Flow Margin | 35.57 | 28.81 | 33.25 | 8.04 | 41.07 | |||||
Unlevered Free Cash Flow Margin | 38.12 | 31.69 | 36.58 | 17.08 | 47.92 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.41 | 0.42 | 0.42 | 0.35 | 0.35 | |||||
Fixed Assets Turnover | 4.75 | 4.7 | 4.48 | 4.48 | 4.88 | |||||
Receivables Turnover (Average Receivables) | 5.65 | 5.16 | 4.74 | 4.19 | 4.56 | |||||
Inventory Turnover (Average Inventory) | 1.65 | 1.62 | 1.42 | 1.16 | 1.27 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.81 | 1.59 | 1.41 | 1.65 | 1.26 | |||||
Quick Ratio | 1.37 | 1.14 | 1 | 1.03 | 0.84 | |||||
Operating Cash Flow to Current Liabilities | 0.9 | 0.76 | 0.62 | 0.46 | 0.5 | |||||
Days Sales Outstanding (Average Receivables) | 64.79 | 70.76 | 76.96 | 87.02 | 80.28 | |||||
Days Outstanding Inventory (Average Inventory) | 222.16 | 225.62 | 256.86 | 313.34 | 289.01 | |||||
Average Days Payable Outstanding | 78.99 | 76.52 | 73.96 | 44.38 | 80.64 | |||||
Cash Conversion Cycle (Average Days) | 207.96 | 219.86 | 259.86 | 355.98 | 288.65 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 355.46 | 507.15 | 1.08K | 1.05K | 1.04K | |||||
Total Debt / Total Capital | 78.04 | 83.53 | 91.55 | 91.3 | 91.2 | |||||
LT Debt/Equity | 352.86 | 503.69 | 1.04K | 1.02K | 973.66 | |||||
Long-Term Debt / Total Capital | 77.47 | 82.96 | 87.51 | 89.12 | 85.72 | |||||
Total Liabilities / Total Assets | 85.05 | 89.05 | 94.38 | 93.59 | 93.6 | |||||
EBIT / Interest Expense | 8.99 | 7.8 | 7.16 | 1.96 | 2.64 | |||||
EBITDA / Interest Expense | 12.48 | 10.68 | 9.72 | 3.01 | 4.19 | |||||
(EBITDA - Capex) / Interest Expense | 11.9 | 9.94 | 9.06 | 2.73 | 3.89 | |||||
Total Debt / EBITDA | 2.58 | 2.66 | 2.9 | 5.34 | 3.96 | |||||
Net Debt / EBITDA | 1.76 | 2.03 | 2.22 | 4.45 | 3.18 | |||||
Total Debt / (EBITDA - Capex) | 2.71 | 2.86 | 3.11 | 5.87 | 4.27 | |||||
Net Debt / (EBITDA - Capex) | 1.85 | 2.18 | 2.38 | 4.89 | 3.43 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.83 | 2.18 | 1.32 | 7.09 | 18.57 | |||||
Gross Profit, 1 Yr. Growth % | 1.36 | 1.35 | 2.01 | -0.71 | 12.61 | |||||
EBITDA, 1 Yr. Growth % | 8.61 | -1.46 | 5.89 | -10.07 | 11.53 | |||||
EBITA, 1 Yr. Growth % | 9.05 | -1.57 | 6.12 | -11.15 | 12.58 | |||||
EBIT, 1 Yr. Growth % | -4.04 | 0.11 | 7.83 | -20.04 | 0.19 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -7.37 | -18.87 | 11.18 | 2.52 | -39.11 | |||||
Net Income, 1 Yr. Growth % | -7.37 | -18.87 | 11.18 | 2.52 | -39.11 | |||||
Normalized Net Income, 1 Yr. Growth % | -9.2 | 3.34 | -7.03 | -23.1 | -12.51 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -4.43 | -16.49 | 17.8 | 3.14 | -39.47 | |||||
Accounts Receivable, 1 Yr. Growth % | 11.54 | 8.18 | 13.65 | 30.65 | -6.69 | |||||
Inventory, 1 Yr. Growth % | 8.62 | 4.96 | 20.66 | 93.06 | -26.48 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -1.85 | 8.55 | 4.45 | 9.76 | 7.71 | |||||
Total Assets, 1 Yr. Growth % | 5.43 | -2.83 | 6.47 | 49.19 | -5.47 | |||||
Tangible Book Value, 1 Yr. Growth % | -10.54 | 6.88 | 19.58 | 61.15 | -10.17 | |||||
Common Equity, 1 Yr. Growth % | -2.73 | -28.79 | -45.36 | 70.23 | -5.7 | |||||
Cash From Operations, 1 Yr. Growth % | 14.72 | -11.77 | 4.97 | -12.86 | 35.64 | |||||
Capital Expenditures, 1 Yr. Growth % | -1.62 | 44.74 | 6.36 | 18.8 | -1.44 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 40.12 | -17.22 | 14.56 | -73.73 | 315.38 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 33.51 | -15.04 | 14.82 | -49.8 | 173.73 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.34 | 10 | 10.23 | 9.79 | 5.63 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.47 | 5.45 | 1.75 | 4.17 | 12.68 | |||||
Gross Profit, 2 Yr. CAGR % | -0.97 | 1.36 | 1.68 | 0.64 | 7.3 | |||||
EBITDA, 2 Yr. CAGR % | 1.14 | 3.37 | 2.13 | -1.93 | 6.52 | |||||
EBITA, 2 Yr. CAGR % | 1.16 | 3.52 | 2.21 | -2.38 | 6.77 | |||||
EBIT, 2 Yr. CAGR % | -5.97 | -2.09 | 3.9 | -6.51 | -2.11 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -6.97 | -13.31 | -5.03 | 6.76 | -20.99 | |||||
Net Income, 2 Yr. CAGR % | -6.97 | -13.31 | -5.03 | 6.76 | -20.99 | |||||
Normalized Net Income, 2 Yr. CAGR % | -9.49 | -1.51 | -2.21 | -14.88 | -8.32 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.24 | -10.66 | -0.82 | 10.23 | -20.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.43 | 9.84 | 10.88 | 21.85 | 10.41 | |||||
Inventory, 2 Yr. CAGR % | 15.07 | 6.77 | 12.53 | 52.62 | 19.14 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.36 | 3.22 | 6.48 | 7.07 | 8.73 | |||||
Total Assets, 2 Yr. CAGR % | -2.65 | 1.21 | 1.71 | 26.03 | 18.76 | |||||
Tangible Book Value, 2 Yr. CAGR % | 50.6 | -2.22 | 13.05 | 38.82 | 20.32 | |||||
Common Equity, 2 Yr. CAGR % | -13.24 | -16.77 | -37.62 | -3.56 | 26.7 | |||||
Cash From Operations, 2 Yr. CAGR % | -3.6 | 0.6 | -3.77 | -4.36 | 8.72 | |||||
Capital Expenditures, 2 Yr. CAGR % | -9.23 | 19.33 | 24.08 | 12.41 | 8.21 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 6.9 | 7.6 | -2.62 | -45.07 | 25.68 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 5.05 | 6.42 | -1.13 | -23.7 | 28.84 | |||||
Dividend Per Share, 2 Yr. CAGR % | 10.1 | 10.17 | 10.11 | 10.01 | 7.69 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.62 | 3.04 | 4.06 | 3.5 | 8.76 | |||||
Gross Profit, 3 Yr. CAGR % | 0.85 | -0.21 | 1.57 | 0.87 | 5.56 | |||||
EBITDA, 3 Yr. CAGR % | 1.41 | 0.27 | 4.63 | -2.27 | 6.5 | |||||
EBITA, 3 Yr. CAGR % | 1.38 | 0.24 | 4.38 | -2.62 | 7.2 | |||||
EBIT, 3 Yr. CAGR % | -3.38 | -3.99 | 1.11 | -4.99 | 1.88 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 54.26 | -11.12 | -5.81 | -2.58 | -11.46 | |||||
Net Income, 3 Yr. CAGR % | 54.26 | -11.12 | -5.81 | -2.58 | -11.46 | |||||
Normalized Net Income, 3 Yr. CAGR % | -6.08 | -4.28 | -3.39 | -9.98 | -7.13 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 66.02 | -6.61 | -2.03 | 0.48 | -9.74 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.81 | 10.99 | 11.1 | 17.11 | 11.48 | |||||
Inventory, 3 Yr. CAGR % | 11.16 | 11.6 | 11.21 | 34.72 | 19.64 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.02 | 5.06 | 3.63 | 7.56 | 7.28 | |||||
Total Assets, 3 Yr. CAGR % | -7.66 | -2.71 | 2.94 | 15.56 | 14.51 | |||||
Tangible Book Value, 3 Yr. CAGR % | 126.94 | 34.33 | 4.57 | 27.23 | 20.07 | |||||
Common Equity, 3 Yr. CAGR % | -28.03 | -18.77 | -27.67 | -12.83 | -4.27 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.07 | -6.41 | 2.04 | -6.9 | 7.45 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.89 | 6.04 | 14.84 | 22.29 | 7.59 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.44 | -1.83 | 10.62 | -37.37 | 22.24 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.65 | -2.13 | 9.82 | -21.23 | 24.65 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.64 | 10.06 | 10.19 | 10.01 | 8.53 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.25 | 2.47 | 2.87 | 3.49 | 7.43 | |||||
Gross Profit, 5 Yr. CAGR % | 1.96 | 0.73 | 1.18 | 0.13 | 3.86 | |||||
EBITDA, 5 Yr. CAGR % | 3.72 | 1.06 | 1.95 | -0.67 | 5.18 | |||||
EBITA, 5 Yr. CAGR % | 3.87 | 1.05 | 1.71 | -1.13 | 5.38 | |||||
EBIT, 5 Yr. CAGR % | 1.57 | -1.03 | -0.53 | -5.39 | -0.13 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 0.92 | -5.26 | 27.05 | -4.36 | -12.21 | |||||
Net Income, 5 Yr. CAGR % | 0.92 | -5.26 | 27.05 | -4.36 | -12.21 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.03 | -1.03 | -3.78 | -9.06 | -5.33 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.32 | 0.08 | 35.11 | -0.21 | -10.11 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.6 | 9.11 | 11.44 | 15.21 | 10.82 | |||||
Inventory, 5 Yr. CAGR % | 9.84 | 8.28 | 11.71 | 26.49 | 14.32 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.54 | 3 | 3.78 | 5.86 | 5.64 | |||||
Total Assets, 5 Yr. CAGR % | -2.5 | -4.65 | -4.02 | 7.9 | 8.99 | |||||
Tangible Book Value, 5 Yr. CAGR % | 67.57 | 36.99 | 71.73 | 36.11 | 10.6 | |||||
Common Equity, 5 Yr. CAGR % | -19.64 | -25.84 | -32.03 | -13 | -9.49 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.53 | -2.21 | -2.75 | -5.59 | 4.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.47 | 3.58 | 7.11 | 8.54 | 12.14 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.53 | 2.46 | 0.8 | -22.12 | 16.25 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 5 | 2.12 | 0.86 | -11.33 | 17.11 | |||||
Dividend Per Share, 5 Yr. CAGR % | 15.16 | 11.97 | 11.02 | 10.04 | 9.18 |
- Stock Market
- Equities
- AMGN Stock
- Financials Amgen Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















